Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide Receptors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07115069
What this trial is testing

Comparison of Body Composition Changes With Weight Loss Interventions

Who this might be right for
Obesity
Vanderbilt University Medical Center 60
Post-approval studies (Phase 4)Looking for participantsNCT06324461
What this trial is testing

GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery

Who this might be right for
Myocardial Injury
The University of Hong Kong 372
Not applicableUnknownNCT06388213
What this trial is testing

Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.

Who this might be right for
Diabetes Mellitus, Type 2AnesthesiaPulmonary Aspiration of Gastric Contents
University Hospital, Geneva 40
Large-scale testing (Phase 3)Study completedNCT01847313
What this trial is testing

The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Karl Neff 20
Testing effectiveness (Phase 2)UnknownNCT02829502
What this trial is testing

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke

Who this might be right for
Ischemic Stroke
Christina Kruuse 30
Not applicableEnrolling By InvitationNCT06581120
What this trial is testing

GLP_1 RA Ultrasound Study

Who this might be right for
Glucagon Like Peptide-1 (GLP-1Delayed Gastric EmptyingRisk of Aspiration+2 more
Children's Hospital Medical Center, Cincinnati 100
Not applicableNot Yet RecruitingNCT07811895
What this trial is testing

Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

Who this might be right for
TirzepatideFrozen Embryo TransferObesity
RenJi Hospital 1,510
Post-approval studies (Phase 4)Study completedNCT02639130
What this trial is testing

GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Diabeteszentrum Bad Lauterberg im Harz 67
Testing effectiveness (Phase 2)Study completedNCT05920889
What this trial is testing

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies

Who this might be right for
StrokeStroke, AcuteStroke, Ischemic+1 more
Chinese University of Hong Kong 140
Testing effectiveness (Phase 2)Looking for participantsNCT06903923
What this trial is testing

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

Who this might be right for
Obesity in ChildrenBone StrengthGLP - 1+3 more
University of Virginia 120
Not applicableStudy completedNCT01767389
What this trial is testing

Glucagon-like Peptide (GLP) Utilization and Safety

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 1
Testing effectiveness (Phase 2)Study completedNCT05895643
What this trial is testing

Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?

Who this might be right for
Alcohol AbuseAlcohol AddictionAlcohol Dependence+1 more
Psychiatric Centre Rigshospitalet 108
Not applicableStudy completedNCT03010683
What this trial is testing

Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusCoronary Artery Disease
University of Athens 60
Testing effectiveness (Phase 2)Study completedNCT02838589
What this trial is testing

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers

Who this might be right for
Stroke
Christina Kruuse 30
Not applicableUnknownNCT04383197
What this trial is testing

Exercise and GLP-1 RA on Insulin Secretion

Who this might be right for
Type 2 Diabetes
University of Copenhagen 30
Not applicableUnknownNCT04733508
What this trial is testing

Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2
Radboud University Medical Center 28
Early research (Phase 1)Looking for participantsNCT07723833
What this trial is testing

Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 152
Testing effectiveness (Phase 2)Looking for participantsNCT07107334
What this trial is testing

Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

Who this might be right for
Endometrioid Endometrial Adenocarcinoma
University of Florida 20
Not applicableStudy completedNCT06774807
What this trial is testing

Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33)

Who this might be right for
Healthy
University of Copenhagen 10
Post-approval studies (Phase 4)UnknownNCT04029272
What this trial is testing

Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients

Who this might be right for
Polycystic Ovary Syndrome
Peking Union Medical College Hospital 80
Next Page